MedTrace Logo

MyoVista Measurements in Patients With Atherosclerosis and CAD

NCT02873052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-10-15

No results posted yet for this study

Summary

The MyoVista system is a novel electrocardiogram technology that provides non-invasive assessment of myocardial abnormalities by analyzing energy changes at the cellular level of the myocardium.

Conditions

Interventions

DEVICE

MyoVista

The clinical set up of MyoVista™ is identical to that of a traditional 12-lead ECG but it obtains and processes signal information in a way that permits much greater resolution of the electrical activity associated with the myocardium MyoVista.

Sponsors & Collaborators

  • Heart Test Laboratories, Inc.

    collaborator INDUSTRY

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    lead OTHER

Principal Investigators

  • Tess Jackovich · VP-Business Development

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2019-09-22
Completion
2020-02-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02873052 on ClinicalTrials.gov